Home LiteratureArticle Details
PMID: 19918005 Published · ppublish English Case Reports Journal Article

Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report.

Diabetes care ·Vol. 33 ·No. 2 ·2010-02-00 ·Pages 375-7

Dirksen C, Hansen DL, Madsbad S, Hvolris LE, Naver LS, Holst JJ, Worm D

Abstract

To examine after gastric bypass the effect of peroral versus gastroduodenal feeding on glucose metabolism. A type 2 diabetic patient was examined on 2 consecutive days 5 weeks after gastric bypass. A standard liquid meal was given on the first day into the bypassed gastric remnant and on the second day perorally. Plasma glucose, insulin, C-peptide, glucagon, incretin hormones, peptide YY, and free fatty acids were measured. Peroral feeding reduced 2-h postprandial plasma glucose (7.8 vs. 11.1 mmol/l) and incremental area under the glucose curve (iAUC) (0.33 vs. 0.49 mmol . l(-1) . min(-1)) compared with gastroduodenal feeding. beta-Cell function (iAUC(Cpeptide/Glu)) was more than twofold improved during peroral feeding, and the glucagon-like peptide (GLP)-1 response increased nearly fivefold. Improvement in postprandial glucose metabolism after gastric bypass is an immediate and direct consequence of the gastrointestinal rearrangement, associated with exaggerated GLP-1 release and independent of changes in insulin sensitivity, weight loss, and caloric restriction.

MeSH Terms
Area Under Curve Blood Glucose/metabolism C-Peptide/blood Diabetes Mellitus, Type 2/blood,complications,surgery Enteral Nutrition Fatty Acids, Nonesterified/blood Gastric Bypass Glucagon/blood Glucagon-Like Peptide 1/blood,metabolism Humans Incretins/blood Male Middle Aged Obesity, Morbid/surgery Peptide YY/blood Postoperative Period Postprandial Period/physiology
Chemicals
Blood Glucose C-Peptide Fatty Acids, Nonesterified Incretins Peptide YY Glucagon-Like Peptide 1 Glucagon
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Dirksen Carsten
Department of Endocrinology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark. cardir@gmail.com
Hansen Dorte L
Madsbad Sten
Hvolris Lisbeth E
Naver Lars S
Holst Jens J
Worm Dorte
References (15)
15 references, click to expand
  1. Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.
    Diabetologia. 2009 Feb;52(2):199-207 PMID: 19037628
  2. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
    Surg Obes Relat Dis. 2007 Nov-Dec;3(6):597-601 PMID: 17936091
  3. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.
    J Clin Endocrinol Metab. 2008 Jul;93(7):2479-85 PMID: 18430778
  4. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.
    Br J Surg. 2006 Feb;93(2):210-5 PMID: 16392104
  5. GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism.
    Obes Surg. 2009 Mar;19(3):313-20 PMID: 18815849
  6. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.
    Diabetologia. 1986 Jan;29(1):46-52 PMID: 3514343
  7. Bariatric surgery: a systematic review and meta-analysis.
    JAMA. 2004 Oct 13;292(14):1724-37 PMID: 15479938
  8. Postprandial changes in gut regulatory peptides in gastric bypass patients.
    Int J Obes (Lond). 2008 Nov;32(11):1640-6 PMID: 18794895
  9. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
    Ann Surg. 2006 Jan;243(1):108-14 PMID: 16371744
  10. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.
    J Clin Endocrinol Metab. 2006 May;91(5):1735-40 PMID: 16478824
  11. Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?
    Obes Surg. 2009 Feb;19(2):217-229 PMID: 18820978
  12. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
    J Clin Endocrinol Metab. 2007 Dec;92(12):4678-85 PMID: 17895322
  13. Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Scand J Gastroenterol. 1979;14(2):205-7 PMID: 432544
  14. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.
    Ann Surg. 2006 Nov;244(5):741-9 PMID: 17060767
  15. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.
    Obesity (Silver Spring). 2008 Feb;16(2):298-305 PMID: 18239636
Article Info
Journal
Diabetes care
Abbr.
Diabetes Care
ISSN
1935-5548
Published
2010-02-00
Epub
2009-00-16
Pages
375-7
Language
English
Region
United States
NLM ID
7805975
PMCID
PMC2809286
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com